Do cats and dogs receive cancer?
Cancer for pets such as cats and dogs is quite common. Dogs tend to develop cancer with approximately the same degree as human beings, while cats are diagnosed somewhat less often. Unfortunately, cancer is the cause of death for about 50% of all pets in ten years.
Some common cancer indicators in pets are symptoms such as persistent or growing swelling on the body, ulcers that refuse to treat, reduced appetite, weight loss or constant fatigue. Although these symptoms may also be proof of other states, all are due to concern and require a trip to the vet.
There are many cancer varieties in cats, dogs and other pets. In female cats and dogs, breast cancer may be common, but the chances of its development can be drastically reduced by an animal spaying at a young age. Cancer of the mouth is a common condition in dogs, although not so much in cats. Lymphoma is a often occurring type of cancer and sometimes chemotherapy can be treated. They can often be the oneabdominal and bone tumors. Rocket in pets is diagnosed with the same methods as cancer in humans: usually through X -rays, blood tests, physical symptoms and especially biopsy, which is to remove a piece of tissue from the body that is considered to be cancer. For treatment, veterinarians use technology such as radiation, chemotherapy, surgery and other methods. A combination of several different treatments is often used.
There is usually no typical result for cancer treatment in pets. As in humans, the sooner the diagnosis is, the better the chance of full recovery. For some cancers, the animal may be able to live a relatively healthy life for many months, although cancer cannot be treated. In others, when painful forms of cancer develop and cannot be treated, euthanization may be necessary. In such cases, animal will be relaxed with sedative and the owner will have the opportunityt to say goodbye.
There are currently many veterinary programs devoted to the treatment and treatment of cancer in domestic animals. They hope to find a medicine over the next 10 to 20 years, which could then lead to cancer drugs.